Redness is an excellent example of why aesthetic-device shopping gets ahead of diagnosis.
A clinic may offer VBeam, IPL, BBL, Excel V or another vascular/light platform and describe all of them as ways to “take down redness.” The color may look similar in the mirror. The underlying pattern, target vessels, skin tone and device physics can be quite different.
For persistent facial erythema and visible vessels—especially in rosacea—the two names consumers most often compare are pulsed-dye laser and IPL. Both can be useful. Neither is a treatment for redness, because redness is not a diagnosis.
Where the choice actually differs
Persistent facial erythema and visible vessels| On | VBeam (pulsed-dye laser) | IPL |
|---|---|---|
| What it is | A laser delivering one wavelength, commonly around 595 nm | Not a laser. Broad-spectrum light filtered into selected ranges |
| What it targets | Hemoglobin in blood vessels | Vascular or pigment targets, depending on the filter |
| Suits | Vascular lesions and persistent erythema | A mixture of redness and sun-related pigment |
| Clearance over 50 percent | No significant difference between the two | No significant difference between the two |
| Clearance over 75 percent | Not favored in the pooled analysis | Showed an advantage in the pooled analysis |
| Reported pain | Lower | Higher |
| Still decided by | Pulse duration, fluence, spot size and cooling | Filter selection and how much pigment is in the skin |
What changes the answer: Four comparative studies and 141 participants between them. That is not enough to declare a winner across rosacea phenotypes, devices, settings and skin tones — and a vascular device treats selected vascular signs, not every feature of rosacea.
One wavelength, or a band someone has filtered
VBeam is a well-known brand of pulsed-dye laser, commonly operating around 595 nm. PDL delivers that single wavelength and is designed to target hemoglobin in blood vessels, which makes vascular lesions and persistent erythema logical indications.
IPL is not a laser. It emits broad-spectrum light and filters it into ranges selected for vascular or pigment targets. That versatility is real and it is also the catch: the broader the band, the more things in your skin are listening.
Four studies is not a winner
A 2024 systematic review and meta-analysis directly comparing IPL and PDL for rosacea included four studies and 141 participants. Neither modality took a statistically significant lead on greater than 50% clearance or change in erythema index. IPL showed an advantage for greater-than-75% clearance in the pooled analysis; PDL had lower reported pain scores.
Read that as what it is: one advantage each, from a pooled sample smaller than a school year group. A more recent systematic review and network meta-analysis of energy-based devices for rosacea finds much the same shape — several modalities improve selected rosacea signs, and no ranking survives contact with the variation between patients.
Which means the device comparison is not where your decision lives. It is a coin with a very slight lean, and the things that actually decide your result are all downstream of it.
Rosacea is more than vessels
Rosacea can involve persistent color, flushing, visible vessels, acne-like inflammatory lesions, burning, stinging and eye symptoms. A vascular device addresses selected vascular manifestations; it does not automatically treat every feature of rosacea.
The American Academy of Dermatology notes that laser therapy can reduce persistent color changes, while medications may be used for acne-like breakouts and other manifestations.
So if a clinic calls the whole condition a “redness problem,” it has already told you it is selling a device rather than treating a disease. Ask which part of the rosacea the machine is expected to change, and what is supposed to happen to the rest of it.
Visible vessels and diffuse redness are related, not identical
A discrete telangiectatic vessel may be approached differently from broad background erythema. Vessel diameter, depth and color can affect wavelength and parameter choice.
That is one reason “VBeam or IPL?” is not answerable from a selfie. Somebody has to look at the face and say which of those things dominates.
Skin tone changes the optical margin
Both PDL and IPL involve light interacting with skin that contains melanin as well as hemoglobin. Darker or recently tanned epidermis can change energy absorption and pigment risk.
Darker skin can absolutely be treated with vascular and light-based technology. But “experienced with all skin types” is the sentence this article exists to refuse, so replace it with three questions that have answers: how often do you treat skin like mine on this exact platform, do you test spot first, and what is your plan if post-inflammatory hyperpigmentation appears at week three?
“Safe for all skin types” is a marketing claim about a machine. You are not a machine.
Purpura is part of the PDL conversation
Some pulsed-dye laser settings can produce purpura—temporary purple bruising-like discoloration caused by vascular injury. Other settings may be designed to minimize purpura.
Ask whether the intended treatment is purpuric or non-purpuric, what that means for the expected result and how long visible discoloration may last. “No downtime” and a purple cheek are difficult phrases to reconcile in the week you booked around.
When brown and red share a face
For selected patients with both vascular redness and sun-related lentigines, IPL’s broad-spectrum approach may let a provider address more than one optical target in a single course. That is a genuine efficiency and the most defensible reason to prefer it.
It is not a default. Melasma, PIH risk, darker skin, recent tanning and the exact vascular pattern can all reverse the recommendation, and one of them — melasma — changes the conversation entirely. If pigment is part of the reason for choosing IPL, read Sun Spots, PIH, or Melasma? Pigment Is Not One Laser Problem before treating “brown and red” as one category. The rest of my treatment coverage lives on Spa Intelligence.
Nine questions that make the device choice answerable
- Is the redness rosacea, discrete vessels, post-inflammatory redness or another diagnosis?
- Am I treating diffuse erythema, visible vessels or both?
- Why PDL rather than IPL—or IPL rather than PDL?
- What exact wavelength/filter and settings strategy are being used?
- Will the PDL settings produce purpura?
- How does my skin tone and recent sun exposure change the plan?
- How many sessions are realistic?
- What rosacea symptoms will this not treat?
- What medication or skincare plan remains necessary?
The device is the last decision, not the first
PDL and IPL are both legitimate tools for selected redness and rosacea, and the evidence gives neither one a trophy. VBeam is a focused vascular instrument. IPL is a broader platform that can take on redness and sun pigment in the same course.
Choose IPL when brown and red genuinely share the face and the skin tone allows it. Choose PDL when the target is vascular, discrete and the pain trade is worth the narrower aim. Then stop choosing, because the rest of the result belongs to the diagnosis, the settings and the person operating the handpiece — and none of those arrive in the box.
Evidence check: Moderate
Evidence level: moderate for PDL and IPL in selected rosacea-related erythema and vascular concerns; direct head-to-head evidence remains limited.
Sources reviewed August 8, 2026:
This article is general education. Persistent or unexplained facial redness can have causes other than rosacea and should be appropriately assessed before cosmetic treatment.